FDA expands use of Pfizer's best-selling pneumonia vaccine - Reuters

Reuters

FDA expands use of Pfizer's best-selling pneumonia vaccine Reuters Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49. The vaccine, which is already approved for use in adults aged 50 and above, and children ... Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49Business Wire (press release) Will Pfizer (PFE) Stock Be Affected by Pneumonia Vaccine Approval?TheStreet.com FDA OKs expanded age indication for Pfizer's Prevnar 13 pneumonia vaccineSeeking Alpha all 5 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNEr9XXHs6keUNbqLxKiynhNw2zNyw&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779156995345&ei=MmCFV_CKDIL63gH2n5PwDA&url=http://www.reuters.com/article/us-pfizer-fda-idUSKCN0ZS2O4
via IFTTT